Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ring-Larsen

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Scandinavian Journal of Gastroenterology|August 23, 2002
Interferon alfa-2b alone or combined with recombinant granulocyte-macrophage colony-stimulating factor as treatment of chronic hepatitis CK Grønbaek, H Bygum Krarup, H Ring-Larsen, et al.
European Heart Journal|December 1, 1985
Bed rest and increased diuretic treatment in chronic congestive heart failureU Abildgaard, J Aldershvile, H Ring-Larsen, et al.
Scandinavian Journal of Gastroenterology|May 1, 1983
Peritoneovenous shunt in treatment of ascites in patients with cirrhosis. A preliminary report with special reference to pathophysiologyJ H Henriksen, A Malchow-Møller, H Ring-Larsen, et al.
Gastroenterology|February 1, 1993
Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trialM Lombard, B Portmann, J Neuberger, et al.
Hepatology (Baltimore, Md.)|December 1, 1994
Assessment of central blood volume in cirrhosis by radionuclide angiography: what does it really mean?J H Henriksen, S Møller, F Bendtsen, et al.
Hepatology (Baltimore, Md.)|January 1, 1996
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites ClubV Arroyo, P Ginès, A L Gerbes, et al.
Alimentary Pharmacology & Therapeutics|March 13, 2010
Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon alpha-2b and ribavirinA Mangia, O Dalgard, N Minerva, et al.
Ugeskrift for Laeger|October 15, 1998
[Pretreatment with prednisolone enhances the effect of human lymphoblastoid interferon in chronic hepatitis B]K Krogsgaard, P Marcellin, C Trepo, et al.
Journal of Hepatology|December 1, 1996
Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial GroupK Krogsgaard, P Marcellin, C Trepo, et al.
Scandinavian Journal of Gastroenterology|January 23, 1998
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot studyI Nordøy, H B Krarup, H Bell, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Scandinavian Journal of Gastroenterology|August 23, 2002
Interferon alfa-2b alone or combined with recombinant granulocyte-macrophage colony-stimulating factor as treatment of chronic hepatitis CK Grønbaek, H Bygum Krarup, H Ring-Larsen, et al.
European Heart Journal|December 1, 1985
Bed rest and increased diuretic treatment in chronic congestive heart failureU Abildgaard, J Aldershvile, H Ring-Larsen, et al.
Scandinavian Journal of Gastroenterology|May 1, 1983
Peritoneovenous shunt in treatment of ascites in patients with cirrhosis. A preliminary report with special reference to pathophysiologyJ H Henriksen, A Malchow-Møller, H Ring-Larsen, et al.
Gastroenterology|February 1, 1993
Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trialM Lombard, B Portmann, J Neuberger, et al.
Hepatology (Baltimore, Md.)|December 1, 1994
Assessment of central blood volume in cirrhosis by radionuclide angiography: what does it really mean?J H Henriksen, S Møller, F Bendtsen, et al.
Hepatology (Baltimore, Md.)|January 1, 1996
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites ClubV Arroyo, P Ginès, A L Gerbes, et al.
Alimentary Pharmacology & Therapeutics|March 13, 2010
Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon alpha-2b and ribavirinA Mangia, O Dalgard, N Minerva, et al.
Ugeskrift for Laeger|October 15, 1998
[Pretreatment with prednisolone enhances the effect of human lymphoblastoid interferon in chronic hepatitis B]K Krogsgaard, P Marcellin, C Trepo, et al.
Journal of Hepatology|December 1, 1996
Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial GroupK Krogsgaard, P Marcellin, C Trepo, et al.
Scandinavian Journal of Gastroenterology|January 23, 1998
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot studyI Nordøy, H B Krarup, H Bell, et al.
Pageof 9